Intimation of Investor Meet

Board & Shareholder Meetings View source PDF

JUBLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.3%1-day move

₹1007.80

prior close

₹1009.75

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2+0.4+0.0+0.2+1.3+0.3-1.0-0.8-1.8-1.5-4.3-4.2+1.7—

Up moveDown movePending

AI summary

Jubilant Pharmova has disclosed a scheduled investor meeting for May 25, 2026 with two institutional investors - Dalton Investments and Marval Capital. The meeting will be held in-person as a group meeting. The company plans to discuss the Q4 FY26 earnings presentation, which will be filed on May 22, 2026 after the quarterly financial results are disclosed. This is a routine disclosure under SEBI's Listing Regulations requiring companies to inform exchanges about management interactions with analysts or institutional investors.

Likely market impact

This is a standard investor relations activity and does not contain any new material information. The scheduled meeting follows the upcoming Q4 FY26 results announcement and signals ongoing engagement with institutional investors.